A government scheme in Coimbatore has successfully diagnosed early-stage chronic kidney disease in 941 individuals, emphasizing the importance of early detection and screening, particularly for ...
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.